Physician profile
Teela J Walker
NPI 1689287583
$1,802.26
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $941 · 2023: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $425.78 | 2022-2023 | Tezspire, Fasenra, Breztri |
| Regeneron Healthcare Solutions, INC. | $207.82 | 2022-2023 | Dupixent |
| Jazz Pharmaceuticals INC. | $199.90 | 2022-2023 | |
| Harmony Biosciences LLC | $136.13 | 2022-2023 | Wakix |
| Inogen, INC. | $123.70 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Glaxosmithkline, LLC. | $115.57 | 2022-2023 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $101.91 | 2022-2023 | Glassia |
| Genzyme Corporation | $99.08 | 2022-2023 | |
| Grifols USA, LLC | $96.01 | 2022-2023 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $86.60 | 2023 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.27 | 2022 | |
| Pharming Healthcare, INC. | $50.79 | 2022-2023 | Ruconest |
| Mylan Specialty L.P. | $31.09 | 2022 | |
| Axsome Therapeutics, INC. | $22.67 | 2023 | Sunosi |
| Novartis Pharmaceuticals Corporation | $20.74 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.26 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teela Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.